Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebocontrolled pilot trial (CANTREAT study)

Documenti analoghi

• Feeding enterally the hemodynamically unstable critically ill patient: experience from a multicentre trial (the REDOXS(© )study)
  di: Dhaliwal, R, et al.
  Pubblicazione: (2009)
• Feasibility of the REDOXS study – reducing deaths due to oxidative stress: a randomized pilot trial of glutamine and antioxidant supplementation in critically ill patients
  di: Heyland, D, et al.
  Pubblicazione: (2007)
• Colonization of the Intestinal Tract of Conventional Mice with Candida albicans and Treatment with Antifungal Agents
  di: Turner, J. R., et al.
  Pubblicazione: (1976)
• Need for expanded Candida Score for empiric antifungal use in medically critically ill patients?
  di: Laine, Melanie E., et al.
  Pubblicazione: (2019)
• Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
  di: Hall, G S, et al.
  Pubblicazione: (1988)